drugset / Trial / NCT06747936
A Study to Evaluate the Efficacy and Safety of Co-administration of AD-2281 and AD-2282
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safetyof co-administration of AD-2281 and AD-2282 in patients with Primary Hypercholesterolemia
Timeline
- Start
- 2025-02
- Primary completion
- 2025-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AD-2282 | Unknown | — | Oral |
| Background | AD-2281 | Unknown | — | Oral |